ABN AMRO Bank’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
ABN AMRO Bank's PFE Position: Q2 2026 in Review
ABN AMRO Bank increased its Pfizer (PFE) stake by 8.6% in Q2 2026, buying an estimated $112K and bringing the position to 54,296 shares worth $1.31M. The position accounts for 0.02% of the portfolio, ranked #150.
ABN AMRO Bank first reported a position in PFE in Q3 2023 and has held it in 7 quarters since. The position peaked at $1.41M in Q1 2026. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- ABN AMRO Bank held 54,296 shares of Pfizer worth $1.31M as of Q2 2026.
- ABN AMRO Bank bought 4,298 Pfizer shares in Q2 2026, an estimated $112K.
- Pfizer made up 0.02% of ABN AMRO Bank's portfolio in Q2 2026, its #150 holding.
- ABN AMRO Bank first reported a position in Pfizer in Q3 2023 and has held it in 7 quarters since.
- ABN AMRO Bank's Pfizer position peaked at $1.41M in Q1 2026.
- 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on ABN AMRO Bank's 13F filing for Q2 2026, filed 6 Aug 2026.